Special Topic: Drug Resistance

The special topic calls for papers on drug resistance and such papers will appear in Advances in Natural Science as a special column.

Affiliated research area: antimicrobial and drug resistance


Special Topics on Drug Resistance include papers on antimicrobial resistance in all medically relevant bacteria, viruses, parasites and fungi including epidemiology and surveillance of resistant microbes, mechanisms of action and resistance, detection of resistance, treatment practice and strategies, and new drug development. Apart from the conventional genetic drug resistance due to chromosomal mutations or mobile genetic elements, phenotypic drug resistance or drug tolerance in microbes including bacterial persisters and biofilms, parasites and fungi, and broad microbial persistence, will also be included.


In addition to the Review and Original Articles by invited speakers, we are inviting you to submit a relevant research paper on Drug Resistance for consideration. Papers will be subject to normal peer review and must comply with the Guide for Authors.

To submit papers to the “Drug Resistance” Special Issue, please go to http://www.cscanada.net. Manuscripts should be submitted by the deadline written above. With your submission, please state clearly to the editor that your manuscripts are submitted to the Special Issue Drug Resistance.


Related Conferences:

International Liver Cancer Association Sixth Annual Conference (ILCA) 2012

September 14 - 16, 2012, Berlin, Germany

18th Congress of the International Society for Human and Animal Mycology (ISHAM) 2012

June 10 - 14, 2012, Berlin, Germany

Advanced Topics in Computational Biology Agrochemical & Drug Design meeting 2012

April 1 - 6, 2012, Sao Paolo, Brazil

Related Journals (Special issue):

"Efflux Pumps of Multi-Drug Resistant Pathogenic Bacteria: Their Genetic Regulation, Molecular Biology and Possible Control with Newly Designed Agents" Antibiotics

"HIV Drug Resistance"

Related Articles:

Alain J Cozzone., An insight into future antibacterial therapy. Emerg Microbes Infect. 2012, 1(11): e38.

David A. Rasko & Vanessa Sperandio, Anti-virulence strategies to combat bacteria-mediated disease. Nature Reviews Drug Discovery, 02/2010; 9(2):117-28.

Richard T. Eastman & David A. Fidock., Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nature Reviews Microbiology, 2009 Dec; 7(12):864-74